Jasper Therapeutics, Inc.JSPRWNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+21.4%
5Y CAGR+79.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+21.4%/yr
Annual compound
5Y CAGR
+79.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
18.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $20.42M | +19.6% |
| 2023 | $17.08M | +3.1% |
| 2022 | $16.57M | +45.2% |
| 2021 | $11.41M | +137.8% |
| 2020 | $4.80M | +339.6% |
| 2019 | $1.09M | - |